SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-24-032568
Filing Date
2024-04-12
Accepted
2024-04-12 16:22:47
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0203688-s3_adial.htm S-3 267827
2 OPINION OF BLANK ROME LLP ea020368801ex5-1_adial.htm EX-5.1 11257
3 CONSENT OF MARCUM LLP ea020368801ex23-1_adial.htm EX-23.1 2274
4 FILING FEE TABLE ea020368801ex-fee_adial.htm EX-FILING FEES 14025
5 GRAPHIC image_001.jpg GRAPHIC 16765
6 GRAPHIC ex5-1_001.jpg GRAPHIC 1804
  Complete submission text file 0001213900-24-032568.txt   322504
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278652 | Film No.: 24841782
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)